FOR IMMEDIATE RELEASE
Monday, Sept. 28, 2020

KINGSTON, Ont. – Queen’s University announced that it has entered into a research collaboration and licensing agreement with Taysha Gene Therapies, Inc., for the development and commercialization of gene therapy for GM2 gangliosidoses.

The GM2 gangliosidoses are a group of degenerative/inflammatory diseases...Read more